Quality Improvement Project Can Reduce Pediatric Head CT Use

Share this content:
Quality Improvement Project Can Reduce Pediatric Head CT Use
Quality Improvement Project Can Reduce Pediatric Head CT Use

MONDAY, March 6, 2017 (HealthDay News) -- A quality improvement (QI) project can decrease use of computed tomography (CT) in the emergency department for children with head injury, according to a study published online March 2 in Pediatrics.

Rebecca M. Jennings, M.D., from Seattle Children's Hospital, and colleagues implemented a validated head trauma prediction rule for traumatic brain injury to assess a QI project in a community emergency department aimed at decreasing the use of head CT scans in children. Key drivers of CT use were identified and decision aids were implemented to improve the use of prediction rules. Maintenance of Certification credit and QI coaching were offered to hospitals. The effect of the intervention on monthly CT scan rates was assessed.

The researchers found that during the baseline period, the CT scan rate was 29.2 percent among 695 patients. After the intervention, the CT scan rate was 17.4 percent among 651 patients (P < 0.01). Targeting providers with variable pediatric experience and parental imaging expectations were identified as barriers.

"We demonstrate that a Maintenance of Certification QI project sponsored by a children's hospital can facilitate evidence-based pediatric care and decrease the rate of unnecessary CT use in a community setting," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »